This CAPRI research line mainly focuses on the neurobiological, psychophysiological and psychological vulnerability and correlates of the comorbidity and interactions between emotion regulation, affective disorders and somatic pathology or functional syndromes, as well as on the diagnostic and therapeutic implications.
In the past, we have extensively examined the clinical impact of childhood trauma and mental health in adulthood in longitudinal designs and from a biopsychosocial perspective. Furthermore, we have investigated posttraumatic stress disorder (PTSD) following civilian traumatic brain injury and we have performed studies on the neurobiology of the heterogeneity of panic disorder.
In the ongoing research projects, we examine the predictive value of personality characteristics and symptom-based subgroups in CFS on the short and long term outcomes of group cognitive behavior therapy. Furthermore, we perform research on several other diverse topics in the field of psychosomatic medicine, such as: cognitive dysfunction in post COVID-19, the impact of severe suicide attempts on the outcomes of major trauma care and the impact of anxiety on postoperative pain.
We also regularly publish case reports, systematic review and/or meta-analyses on several clinical topics, such as for instance: the risk of antidepressant-induced hyponatremia, the prevalence of psychiatric syndromes in sarcoidosis or reports on rare but interesting clinical cases.
Finally, a current research line focuses on the effects of certain emotion regulation strategies (e.g. experiential avoidance, dampening, rumination) on psychiatric symptomatology.